TELA TELA Bio, Inc.

NASDAQ
$0.64

TELA Bio, Inc. (TELA) is expected to report earnings on November 9, 2026, after the market close. The consensus earnings estimate is a loss of $0.19 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -28.4% since its last earnings release on August 10, 2026.

TELA Bio Missed Consensus Estimates, Withdraws Guidance
Monday, August 10, 2026 · 4:05 PM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 9
Monday · 4:05 PM ET
Earnings Whisper
-
vs ($0.19)
Rev est $18.9M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $0.70

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About TELA Bio, Inc.

TELA Bio, Inc. is a commercial-stage medical technology company focused on providing innovative technologies that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's own anatomy.

Sector

Healthcare

Industry

Medical Instruments/Supply